Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Liver Metastases 1Leukemia, T-Cell 1Leukemia 1Disease 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 11Cytarabine 8Methotrexate 6Etoposide 6Dexamethasone 6Vincristine 5Radiotherapy 5Doxorubicin 5Daunorubicin 5pegaspargase 4Trimethoprim, Sulfamethoxazole Drug Combination 4Mercaptopurine 4Idarubicin 4gamma-Globulins 3fludarabine phosphate 3Whole-Body Irradiation 3Prednisone 3N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3Methylprednisolone 3Gemtuzumab 3Filgrastim 3Clofarabine 3Ciprofloxacin 3Busulfan 3etoposide phosphate 2blinatumomab 2Thioguanine 2Melphalan 2Karyotyping 2Injections, Spinal 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Leukemia × Positron Emission Tomography Computed Tomography × Clear all
NCT03564704 2018-06-21

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
80 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡